Skip to content

Biodesix, Inc. BDSX Change in AR

Change in AR at other companies

NeoGenomics logo
NeoGenomicsNEO
$8.18M+1,125%
Veracyte logo
VeracyteVCYT
$5.57M-21.1%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
-$2.05M-210%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$3.18M-212%
Guardant Health logo
Guardant HealthGH
-$942K-115%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
-$1.99M-104%

Other financials

Income statement

See full
Revenue$25.6M+42.3%
Operating income-$6.2M+32.1%
Net income-$7.8M+29.8%
EPS (diluted)-$0.81+46.7%

Balance sheet

See full
Cash & equivalents$25.6M+45.3%
Total debt$71.6M+15.0%
Total equity$9.1M-17.4%
Total assets$94.6M+9.7%

Cash flow

See full
Operating cash flow-$10.2M-18.2%
CapEx$81.0K+9.5%
Free cash flow-$10.2M-18.1%

Valuation

See full
Market cap$233.52M+476%
Enterprise value$279.56M+204%
P/S2.4×+1.9×

Profitability

See full
Operating margin-26%-7.5pp
Net margin-33.3%-9.3pp
FCF margin-26.8%-9.6pp

Returns & leverage

See full
Return on equity-316.5%
Debt / equity7.8×+2.2×
Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biodesix, Inc.'s change in AR?
Biodesix, Inc. (BDSX) reported change in AR of $488K in Q1 2026.
How has Biodesix, Inc.'s change in AR changed year-over-year?
Biodesix, Inc.'s change in AR increased by 154.0% year-over-year, from -$904K to $488K.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.